Home / Inspections / 1055208

FDA Inspection 1055208 — KUPI Reproductive Endocrinology & Infertility Lab

KUPI Reproductive Endocrinology & Infertility Lab — FEI 3003934351

The FDA completed an inspection of KUPI Reproductive Endocrinology & Infertility Lab on May 2, 2018 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 2, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Overland Park, KS (United States)

Facility

Other inspections at this facility

  • 1240683 (NAI Thu May 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1199015 (VAI Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 969078 (NAI Fri Apr 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 889600 (NAI Thu Jul 31 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 761532 (NAI Mon Jan 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources